Mohammed Lamorde - Infectious Diseases

Author Information

Mohammed Lamorde is a prominent researcher affiliated with the Infectious Diseases Institute at Makerere University in Kampala, Uganda. His work primarily focuses on infectious diseases, with a significant emphasis on the implementation and optimization of antiretroviral therapies, particularly in low-income and middle-income countries. He has also contributed to research on COVID-19, tuberculosis, and pharmacokinetics, reflecting his broad expertise in the field of infectious diseases.

Research Contributions

Mohammed Lamorde has made substantial contributions to the field of infectious diseases, with particular attention to HIV/AIDS management in resource-limited settings. His research includes the implementation of long-acting antiretroviral therapy, exploring healthcare workers' psychosocial well-being during the COVID-19 pandemic, and optimizing disease isolation unit management. He has also studied the pharmacokinetics of antiretroviral drugs in combination with antimalarial treatments, illustrating his commitment to improving therapeutic strategies for co-infected patients.

Aliases

Mohammed Lamorde is also known by other names, including M Lamorde and M. Lamorde. These aliases may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	2824
H-index	30
Paper Count	216

Publications:

Implementation of long-acting antiretroviral therapy in low-income and middle-income countries.

DOI: 10.1097/COH.0000000000000732

Year: 2022

Willingness to pay for an mHealth anti-retroviral therapy adherence and information tool: Transitioning to sustainability, Call for life randomised study experience in Uganda

DOI: 10.1186/s12911-022-01782-0

Year: 2022

Implementation of long-acting antiretroviral therapy in low-income and middle-income countries

DOI: 10.1097/COH.0000000000000732

Year: 2022

High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study

DOI: 10.1111/hiv.13260

Year: 2022

“Sometimes You Reach a Point Where You Feel Burnt Out”, Job Satisfaction and Psychosocial Well Being of COVID-19 Frontline Health Workers: a Qualitative Study in Two Ugandan COVID-19 Treatment Centres.

DOI: 10.21203/RS.3.RS-153208/V1

Year: 2021

Corrigendum: Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda

DOI: 10.1002/cpt.2395

Year: 2021

Optimizing Highly Infectious Disease Isolation Unit Management: Experiences From the Infectious Diseases Isolation and Research Unit, Fort Portal, Uganda

DOI: 10.1017/dmp.2021.339

Year: 2021

Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine.

DOI: 10.1093/jac/dkab022

Year: 2021

Factors Associated with Uptake of Contraceptives among HIV Positive Women on Dolutegravir based Anti-Retroviral Treatment at Health Centres of Kampala Capital City Authority. A cross sectional study in Uganda.

DOI: 10.21203/RS.3.RS-404132/V1

Year: 2021

Implementation of TB preventive therapy in Uganda: effect of an intervention on completion rates.

DOI: 10.5588/ijtld.20.0100

Year: 2021

Are There Risks Associated with Imaging?

Which Infectious Diseases Can Be Transmitted?

Why is the DTaP Vaccine Important?

How is Chlamydia Diagnosed?

Can it be prevented?

What is the Global Impact of Zika Virus?

What are the Challenges in Malaria Control?

What is the Role of B Cells in Vaccination?

What Are Antigen Presenting Cells?

What are the benefits of using Dexamethasone in COVID-19?

Partnered Content Networks

Relevant Topics